Notes

A novel pneumococcal protein-polysaccharide conjugate vaccine depending on biotin-streptavidin.
To assess the cadmium (Cd) phytoremediation of three native plant species from Padeang zinc (Zn) mine area (Chromolaena odorata, Impatiens patula, and Gynura pseudochina), a hydroponic experiment was performed in nutrient solutions containing various concentrations of Cd (0, 5, 10, 20, and 50 mg L-1) for 15 days. In the hydroponic experiment, C. odorata showed significantly higher total Cd content than those grown in 50 mg L-1 Cd solutions. Only C. odorata and I. patula were chosen for the pot experiment. The plants were grown in spiked Cd-contaminated soils for 90 days, with different concentrations of Cd (0, 20, 40, 60, and 80 mg kg-1). The results from the pot experiment revealed that both species accumulated more Cd in their root parts, with translocation factor values less then 1. C. odorata exhibited the highest biomass production, relative growth rate, and Cd uptake or removal. The findings of the study clearly demonstrate the best uptake of C. odorata in Cd phytoremediation. STZ inhibitor Novelty statementEven though Chromolaena odorata, Impatiens patula, and Gynura pseudochina have been reported as a Cd accumulator but the assessment of these species by nutrient medium and the soil was not undertaken so far. The discovery of new Cd-accumulator plants has been hindered by the lack of efficient assessing. To assess the suitability of specific species of tropical plants that are able to uptake high amounts of Cd without risk of toxicity under conditions similar to the actual field study, is a novelty.Research shows promise for cognitive interventions for children diagnosed with brain tumors. Interventions have been delivered approximately 5 years postdiagnosis on average, yet recent evidence shows cognitive deficits may appear near diagnosis. The present study assessed the feasibility and initial effects of working memory training in children with brain tumors delivered soon after diagnosis and followed 2 years postdiagnosis. Children completed baseline assessments 10 months postdiagnosis and were randomized to complete adaptive or nonadaptive (i.e., control) Cogmed Working Memory Training. Children were administered the WISC-IV Working Memory Index (WMI) and NIH Toolbox Cognitive Battery (NTCB), and parents completed attentional and executive function measures at four time points. On average, participants completed half of prescribed Cogmed sessions. Retention for the three follow-up assessments proved difficult. For both Cogmed groups, WMI and NTCB scores significantly improved immediately postintervention compared to baseline scores. Significant differences were not maintained at the remaining follow-ups. There was preliminary evidence for improved executive function at the final follow-up on parent-reported measures. Working memory training closer to diagnosis proved difficult, though results suggest evidence of cognitive improvement. Future studies should continue to examine potentially efficacious interventions for children with brain tumors and optimal delivery windows to maximize impact.
Minimally invasive surgery (MIS) is increasingly being used for bunion correction, but limited patient outcome data have been reported for third-generation minimally invasive chevron/Akin (MICA) techniques. The aim of this study was to report on radiographic outcomes, pain control, satisfaction, learning curve, and complication rates in a consecutive series of 94 patients undergoing MICA procedures for hallux valgus. It also describes strategies for avoiding perioperative complications that may arise with MIS bunionectomies.

The treating surgeon's first 94 MICA procedures were included in the study. Radiographs were reviewed to measure pre- and postoperative intermetatarsal angles (IMAs), hallux valgus angles (HVAs), and soft tissue/bony foot width. Outcome measures, including visual analog scale (VAS) scores and Coughlin satisfaction scores, were obtained. Complication rates were retrospectively assessed though chart review. Statistical analysis was performed using Student
test for continuous variablen, high patient satisfaction, and low frequency of complications. In addition, the learning curve for the procedure was not as steep as previously reported.

Level III, retrospective comparative series.
Level III, retrospective comparative series.
Chemotherapy-induced vocal fold motion impairment (CIVFMI) is a rare complication of cancer therapy with potential for airway compromise. The objective of this review is to present 2 new cases of CIVFMI to add to the literature as well as characterize the demographics, symptoms, exam findings, airway complication rates and prognosis of CIVFMI.

A search of Pubmed/MEDLINE (1970 to May 1, 2020), Embase (1970 to May 1, 2020), and Cochrane Library using medical study heading (MeSH) terms related to chemotherapy (
) and vocal cord motion impairment (
,
) was performed. Exploratory pooling of data without formal meta-analysis was performed.

A preliminary search yielded 148 abstracts, review articles and studies. A total of 23 studies met inclusion criteria. There were 35 total cases presented in the literature, with a mean age of 29.5 (0.4-78). The most common cancer diagnosis was acute lymphoblastic leukemia (n = 15, 42.9%), and the most common agent was vincristine (n = 30, 85.7%). Dysphagia, bilateral CIVFMI, and vocal fold immobility rather than hypomobility were more common in pediatric patients. There were 8 cases of surgical airway intervention, including tracheostomy and posterior cordotomy. The duration of symptoms was 7 to 420 days, and spontaneous resolution was reported in 32 cases.

CIVFMI has potential for airway complications requiring surgical intervention. Spontaneous resolution after cessation of the offending agent is the most likely outcome. Bilateral CIVFMI, dysphagia and vocal fold immobility are more common in the pediatric population.
CIVFMI has potential for airway complications requiring surgical intervention. Spontaneous resolution after cessation of the offending agent is the most likely outcome. Bilateral CIVFMI, dysphagia and vocal fold immobility are more common in the pediatric population.
Read More: https://www.selleckchem.com/products/Streptozotocin.html